ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.7173C>T (p.Asp2391=)

gnomAD frequency: 0.00001  dbSNP: rs374509926
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040646 SCV000064337 likely benign not specified 2012-09-01 criteria provided, single submitter clinical testing Asp2391Asp in exon 31 of TTN: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 3/8600 European Amer ican chromosomes by the NHLBI Exome sequencing project in a broad population (ht tp://evs.gs.washington.edu/EVS). Asp2391Asp in exon 31 of TTN (allele frequenc y = 3/8600) **
Eurofins Ntd Llc (ga) RCV000725211 SCV000335020 uncertain significance not provided 2015-09-09 criteria provided, single submitter clinical testing
GeneDx RCV000040646 SCV000530965 likely benign not specified 2016-08-12 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV001088352 SCV000643620 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2023-12-09 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000040646 SCV001879690 likely benign not specified 2020-11-25 criteria provided, single submitter clinical testing
Ambry Genetics RCV002362636 SCV002662023 likely benign Cardiovascular phenotype 2021-05-09 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.